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ABSTRACT 
 
ISOLATION AND CHARACTERIZATION OF AN ADHESIN PROTEIN FROM 
THE SURFACE OF A RESPIRATORY PATHOGEN MORAXELLA 
CATARRHALIS 
 
 
TOLGA TURAN 
 
M.S in Molecular Biology and Genetics 
Supervisor: Assoc. Prof. Kamruddin Ahmed 
August 2002, 59 pages 
 
 
 Moraxella catarrhalis is a member of the normal flora of upper respiratory 
tract. Starting in the early 1980s it gained importance as an important cause of otitis 
media in children and lower respiratory tract infections in adults with chronic 
obstructive pulmonary disease. β-lactamase producing strains of M. catarrhalis has 
been increasing at a very fast rate. In some locations, 100% of the strains are β-
lactamase producer. The pathogenesis of infection by this bacterium is not clearly 
understood which hindered the development of a vaccine. In this study, a surface 
protein of about 55 kDa was isolated from M. catarrhalis by celite chromatography. 
It is a heat stable protein and is not affected by 2-mercaptoethanol or dithiothreitol 
treatment. The immunogenic property of the protein has been determined by 
immunizing rabbits with M. catarrhalis and detecting the antibody response in serum 
against 55 kDa protein by Western blotting. In addition, the protein is immunogenic 
in humans as antibody against 55 kDa protein can be detected in the sputum of 
patients with M. catarrhalis infection. Moreover, we determined upto 40 amino acids 
at the N-terminal and also two fragments of the protein. To determine the function of 
the protein, attachment inhibition assays were performed and it was found that 55 
kDa protein competetively inhibits attachment of M. catarrhalis to human 
pharyngeal epithelial cells (HPEC). Similarly, monoclonal antibody against 55 kDa 
(mAb) blocks the protein and inhibits the attachment of M. catarrhalis to HPEC. 
These two lines of evidence show that 55 kDa protein is an adhesin of M. catarrhalis 
which mediate attachment to HPEC. In addition, immunoflourescence experiments 
further verified that 55 kDa protein binds to HPEC. To sequence the gene encoding 
55 kDa protein, PCR was done using degenerate primers constructed from the N-
terminal amino acid sequence. PCR amplification of the possible gene of 55 kDa 
protein resulted  in a 500 bp fragment, but no homology can be obtained with N-
terminal amino acid sequence.  In addition, a genomic library of M. catarrhalis is 
prepared and screened with mAb and with a radiolabelled oligonucleotide probe. We 
isolated several positive clones; therefore in future it might be possible to sequence 
the gene encoding 55 kDa protein from these clones. 
 
Keywords: Moraxella catarrhalis, adherence, attachment inhibition asssay, adhesin. 
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ÖZET 
MORAXELLA CATARRHALIS BAKTERİSİNİN YÜZEYİNDEN BİR ADHESİN 
PROTEİNİNİN İZOLE EDİLMESİ VE KARAKTERİZASYONU 
 
 
TOLGA TURAN 
 
 
Moleküler Biyoloji ve Genetik Yüksek Lisans 
Tez Yöneticisi: Doç. Dr. Kamruddin Ahmed 
Ağustos 2002, 59 sayfa 
 
 
 
 
 İnsan boğaz florasının bir üyesi olan Moraxella catarrhalis, 80’li yılların 
başından itibaren bir patojen olarak önem kazanmaya başlamıştır. M. catarrhalis 
çocuklarda orta kulak iltahabı ve yetişkinlerde (özellikle kronik bronşit hastalarında) 
alt solunum yolu enfeksiyonunda en çok karşılaşılan üçüncü bakteridir. Antibiyotik 
dirençli suşların son zamanlarda çok artması (bir çok yerde 100%) ve bu bakteriye 
karşı başarılı bir aşı geliştirilememiş olması, M. catarrhalis üzerine yapılan 
çalışmaları arttırmıstır. Bu çalışmada molekül ağırlığı 55 kDa olan bir protein M. 
catarrhalis’in yüzeyinden celite kromatografisi metoduyla izole edilmiştir. Bu 
proteinin ısı dirençli olduğu ve 2-merkaptoethanol ve DTT tarafından etkilenmediği 
bulunmuştur. Proteinin immunojenik olduğu tavşan ve insanda yapılan deneyler 
sonucu ispatlanmıştır. Buna ek olarak proteinin amino kısmından 40 amino asitlik 
bölümü Edman metoduyla belirlenmiştir. Proteinin bakteride adhsin olarak görev 
yaptığı bağlanma inhibisyonu deneyleriyle gösterilmiştir. Bu deneylerde 55 kDa 
proteininin insan boğaz epitel hücreleriyle inkübe edilmesi M. catarrhalis’in boğaz 
hücrelere bağlanmasını azaltmıştır. Benzer mantıkla bu proteine karşı üretilmiş 
monoklonal antikorun M. catarrhalis ile inkübe edilmesi bakterinin hücrelere 
bağlanmasını azaltmıştır. Bu proteinin boğaz epitel hücrelerine bağlandığı 
immunofloresans metodu ile de gösterilmiştir. 55 kDa proteini kodlayan genin 
klonlanması için protein sekansından elde edilen dejenere primerlerle PCR 
yapılmıştır. Sonuç olarak 500 bazlık bir fragman elde edilmiştir ama bu fragmanın 
amino asit zinciriyle homolog olmadığı görülmüştür. Buna ek olarak M. catarrhalis 
genomundan hazırlanan gen kütüphanesi monoklonal antikor ve radyoaktif işaretli 
bir oligonukleotid ile taranmıştır. Çıkan pozitif kolonilerin sekanslanması sonucu 
elde edilen bilgiler amino asit zinciriyle karşılaştırılmış fakat homoloji 
bulunamamıştır. Elde edilen pozitif klonlar sonuna kadar henüz sekanslanmamıştır.  
 
Anahtar Kelimeler: Moraxella catarrhalis, bağlanma, bağlanma inhibisyon deneyi, 
adhesin. 
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CHAPTER 1: INTRODUCTION 
 
1.1 MORAXELLA CATARRHALIS 
Moraxella (Branhamella) catarrhalis, formerly called Neisseria catarrhalis 
or Micrococcus catarrhalis is a gram-negative aerobic diplococcus frequently 
found as a normal inhabitant of human respiratory tract. Over the last 20 years, 
this bacterium has emerged as a pathogen (Johnson 1981) and is now considered 
as an important cause of respiratory tract infection and otitis media together with 
Heamophilus influenzae and Streptococcus pneumoniae.    
 
1.1.1 History of Classification 
 Although M. catarrhalis is now accepted as a pathogen, its classification has 
generated controversy since Pfeiffer’s designation as Mikrococcus catarrhalis in 
1896 (Frosch 1896). Subsequent studies reported that M. catarrhalis was a 
common inhabitant of the oropharynx of healthy adults. It was classified as 
Neisseria catarrhalis based on phenotypic characteristics and the colony 
morphology (Enright 1997). Unfortunately, this latter study failed to differentiate 
M. catarrhalis from the commensal bacterium Neisseria cinera. Thus M. 
catarrhalis was not considered as a pathogen for a significant portion of this 
century and most clinical laboratories neglected to test for it in biological fluids 
collected from patients. In 1970, DNA hybridization studies showed that little 
homology existed between M. catarrhalis and Neiseriaceae species, influencing 
its reclassification as Branhamella catarrhalis (Karalus 2000). However, Bovre 
proposed a division of genus Moraxella into two subgenera, Moraxella and 
Branhamella (Bovre 1979). To date the controversy over the nomenclature of 
this bacterium remains unresolved, although most investigators now use 
Moraxella catarrhalis. 
 
1.1.1.1 Identification and Bacteriological Properties 
 Laboratory identification of M. catarrhalis is not difficult:  It is a gram-
negative diplococcus. It is positive for cytochrome oxidase, DNase and tributyrin, 
4-methylumbelliferyl butyrate as well as indoxyl acetate esterases. It fails to 
produce acid from glucose, maltose, sucrose, lactose and fructose; it can grow at 
22 °C on nutrient agar; it fails to grow on modified Thayer-Martin medium and it 
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can reduce nitrate and nitrite (Doern 1990). In addition, modern DNA technology 
has opened new avenues for the detection of M. catarrhalis in clinical materials. 
Particularly, PCR is the most convenient method of modern molecular biology to 
identify microorganisms (Verduin, 2002). Recently, multiplex PCR has been 
designed for detection of major pathogens in middle ear infections (H.  
influenzae, M.  catarrhalis and S.  pneumoniae) (Hendolin, 2000). 
 
1.1.2 Importance 
 M. catarrhalis had been known as a harmless commensal for a significant 
portion of this century. How or why did it suddenly emerge as a pathogen is not 
yet known. However, the following two factors might be responsible: 
1. The bacterium may have changed such that it is now more virulent than in 
past decades. 
2. Since M. catarrhalis has long been regarded as a nonpathogenic 
commensal, infections by the organism may have been occurring  but 
have been overlooked for years. 
 M. catarrhalis is an important pathogen to explore because the infections it 
causes results in a high level of morbidity and mortality and a substantial 
financial burden. For example, in USA, it is responsible for about 15-20 % of all 
otitis media cases in children (Enright 1997) and this represents a substantial 
financial burden ($2 billion/year in US) on the health care system (Murphy 
1996). 
 Although, M. catarrhalis is now an established pathogen all over the world, 
its virulence factors remain to be discovered. Moreover the pathogenesis of this 
bacterium is also not yet clear. In addition, substantial increase in β-lactamase 
producing M. catarrhalis makes it difficult to treat with commonly used 
antibiotics (Martinez, 1998). Therefore new preventive and therapeutic strategies 
are urgently needed to combat infections by this bacterium. All these factors 
motivated us to study M. catarrhalis. 
 
1.1.2.1 M. catarrhalis Infections 
 In children, M. catarrhalis is a major cause of otitis media together with H. 
influenzae and S. pneumoniae (Catlin 1990, Murphy 1996, Christensen 1999). 
Studies on infants and young children by various groups in United States, 
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Norway, Finland, Japan and Spain used tympanocentesis to demonstrate that 15 
to 20 % of the otitis media cases were caused by M catarrhalis (Del Beccaro 
1992). This infection rate is significant as it is estimated that 70 to 80% of all 
children will have had at least a single episode of middle ear disease by the age 
of three years. Recent data from various centers throughout the US show that M. 
catarrhalis is responsible for over 3 million episodes of otitis media annually and 
repeated episodes of otitis media may result in hearing loss and are associated 
with developmental and learning problems as children reach school age (Murphy 
1996). 
 M. catarrhalis is one of the major cause of respiratory tract infection (RTI) in 
adults especially in adults having an underlying disease such as chronic 
obstructive pulmonary disease (COPD). M. catarrhalis is one of the most three 
common causes of exacerbation in COPD patients, together with H. influenzae 
and S. pneumoniae. The reason why M. catarrhalis infection is low in healthy 
adults is thought to be due to the strong immune system in these individuals. 
Therefore M. catarrhalis cause more infection in children whose immune system 
is immature and in old people whose immune system is weak (Verduin 2002).  
 Occasionally, the bacterium causes systemic infections, e.g., meningitis and 
sepsis (Catlin 1990). In addition, M. catarrhalis may cause sinusitis, tracheitis, 
bronchitis, pneumonia and less commonly, ocular infections in children (Verduin 
2002). Although rare, M. catarrhalis can cause sinusitis (Brorson 1976), septic 
arthritis (Craig 1983), bacteremia (Cimolai 1989), cellulitis (Rotta 1994), 
osteomyelitis (Prallet 1991), endocarditis (Douer 1977), and pericarditis. 
(Kostiala 1989). It is also important to note that nosocomial infections could be 
caused by M. catarrhalis (Omori, 1999). 
 
1.1.3 Level of Fight with M .catarrhalis 
 Because very short time has passed since this organism stepped on stage as a 
pathogen; the level of knowledge on it is scarce. Both the virulence factors and 
the pathological properties of M. catarrhalis remain largely unknown. The 
virulence factors should be explored further to understand the pathogenesis of 
this bacterium and to develop protective means against the organism.  
 One additional reason for the low level of knowledge on M catarrhalis is the 
lack of a good animal model. M. catarrhalis is a strict human pathogen and it 
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doesn’t cause infection in mouse or in other small laboratory animals. The best 
models available are the Murine Pulmonary Clearance Model (Unhanand 1992) 
and the SCID (Severe Combined Immunodeficient) mouse model (Harkness 
1993). In the pulmonary clearance model, mice are challenged by introducing 
bacteria into their lungs and the rate of clearance is followed as a measure of the 
immune response. In SCID mouse model, bacteria are introduced by multiple 
routes including intranasal and intravenous, but the symptoms produced in these 
animals do not  mimic those seen in human infection.  
 It has been difficult to combat with M. catarrhalis as more and more β-
lactamase positive strains emerge. The first β-lactamase-positive clinical strain 
was isolated in 1977 (Hoi-Dang 1978). Subsequently, resistance to β-lactams has 
increased at very fast rate. Presently, in North America and Europe almost 100% 
of the strains are β-lactamase producer (Clavo-Sanchez 1997). However it varies 
from country to country such as in Japan it is 94% (Martinez 1998), in Kuwait 
it’s 57% (Ahmed 1999) and in Uganda it’s 100% (Yoshimine 2001). Although 
the reason is not known, it is thought that increased use of antibiotics has 
contributed for this dramatic increase of β-lactamase producing strains. However, 
such increase has not been demonstrated in other bacteria under the same 
selective pressure (Felmingham 1999).  
  The β-lactamase enzymes of M. catarrhalis have been designated as BRO β-
lactamase. BRO is different from other β-lactamases and has only been identified 
in two other Moraxella species (Wallace 1989). The suspected location of the  
bro genes on the chromosome and the high efficiency of transfer tend to support 
theory of a conjugal transposon as a method for spread of resistance (Wallace 
1989).  This different means of spread of resistance might be the reason of the 
steep increase of antibiotic resistance in M. catarrhalis.  
  The emergence of β-lactamase-positive strains motivated scientists to find a 
vaccine against M. catarrhalis. But vaccine development for M. catarrhalis is 
only in the antigen identification stage. 
    Surface exposed antigens of M. catarrhalis are mainly the outer membrane 
proteins, other surface proteins and the lipooligosaccharide. Studying surface 
exposed antigens will not only be a progress in vaccine development but also 
help us to understand the virulence properties of M. catarrhalis since the surface 
 5 
exposed antigens are the sites where the bacterium interacts with the host. In this 
respect our work on the characterization of a surface exposed protein of M. 
catarrhalis will be an important contribution to the understanding of 
pathogenesis and prevention of infection caused by this bacterium.  
 
1.1.4 Surface Exposed Antigens 
 The outer membrane proteins (OMPs) of M. catarrhalis are similar to other 
gram-negative bacteria in that 10 to 20 OMPs are present with 6 to 8 of these 
proteins predominating (Murphy 1990). The outer membrane of M. catarrhalis 
contains 8 major OMPs that are labeled OMP A through OMP H. The molecular 
weight of these proteins ranges from 98 to 21 kDa. An interesting finding was the 
striking homogeneity of OMPs among 50 strains. This means that an immune 
response against one strain will recognize a subsequent strain also (Bartos 1988). 
 Following is the list of the major OMPs of M. catarrhalis: 
 
CopB: 
 CopB was one of the first OMP studied. It exhibits moderate degree of 
antigenic conservation among strains tested (Karalus 2000). There are 3 lines of 
evidence to say that an antigen is conserved:  
• Antibody reactivity 
• Restriction Fragment Length Polymorphism (RFLP) 
• Comparison of sequence of the gene 
 
 The protein is immunogenic as the antibody against it could be detected in 
convalescent sera of patients (Sethi 1995). Moreover, passive immunization of 
mice with the antibody against CopB resulted in enhanced clearance of M. 
catarrhalis from the lungs of these animals (Karalus 2000). Mutation and 
expression analysis show that CopB is involved in iron acquisition. Iron is an 
important element for many bacteria to live on their mammalian hosts. Therefore 
bacteria developed strategies to transfer low concentration of iron from their 
environment.  
 
OMP CD: 
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 Sequence analysis and RFLP studies on OMP CD show high degree of 
conservation among different strains of M. catarrhalis. It is a heat-modifiable 
protein that was initially reported as OMP C and OMP D. Then it was realized 
that these two bands were the two forms of a single antigen. BLAST search 
shows that the protein has homology with Pseudomonas aeruginosa porin protein 
(Murphy 1993). The antibody against OMP CD elicit complement-mediated 
bactericidal activity against various strains of M. catarrhalis which indicate it 
may stimulate a protective immune response if used as a vaccine.   
 
UspA1 and UspA2: 
 They were first named as High Molecular Weight OMP (HMW-OMP) since 
the protein forms oligomeric complexes. Later on it was realized that the 
complex was composed of two proteins and named as ubiquitous surface protein 
A1 and A2 (UspA1 and UspA2). They were characterized as a single protein not 
only because of a single band in Sodium Dodecyl Sulphate Polyacrylamide Gel 
Electrophoresis (SDS-PAGE ) but also because they share a common epitope. In 
fact they share a common 140-aminoacid region that is 93% identical (Cope 
1999). In addition, passive immunization of mice with the antibody against CopB 
resulted in enhanced clearance from the lungs of these animals (Karalus 2000). 
 
Fimbriae : 
 Fimbriae have been described on the surface of M. catarrhalis by electron 
microscopy (Ahmed 1994). In M. catarrhalis, fimbriae are responsible for 
adherence and hemagglutination, therefore thought to be an important virulence 
factor (Ahmed 1992a).  It was also found that fimbriae are present on all fresh 
isolates of M. catarrhalis, and it decreases in number upon repeated in vitro 
passages (Ahmed 1992). Since fimbriae has not been isolated, little information 
available regarding the characterization of these structures. 
Lipooligosaccharide(LOS)  
 Another prominent bacterial surface component of M. catarrhalis is the LOS. 
M. catarrhalis LOS shares homology with LOS of other gram-negative bacteria. 
In addition, these shared LOS epitopes have been implicated as a virulence factor 
 7 
for M. catarrhalis i.e. resistance to bactericidal activity mediated by normal 
human serum (Zaleski 2000). There are three major LOS serotypes in M. 
catarrhalis: A, B and C. these structures encompass 95% all strains studied to 
date (Rahman 1996). Recently, it has been suggested that LOS may act as an 
adhesin of M. catarrhalis (Hu, 2001). 
1.1.5 Typing and Epidemiology 
 The worldwide distribution of M. catarrhalis as well as nosocomial outbreaks 
by this bacterium, provide an opportunity for considering epidemiological 
studies. Several epidemiological typing methods have been used to characterize 
strains of M. catarrhalis, such as phenotypic characterization, electrophoretic 
mobility of esterases, OMPs, whole-cell proteins, plasmid profile, isoelectric 
focusing of β-lactamase enzymes, bacteriocin typing, haemagglutination, 
fimbriation and serotyping; however, these methods could not satisfactorily 
discriminate interstrain variability. The RFLP has been also used for M. 
catarrhalis; however the result was not satisfactory due to many fragments, 
which are difficult to compare. Pulsed field gel electrophoresis (PFGE) was 
successfully used to find out inter-strain variation of M. catarrhalis isolated from 
sputum of patients with RTI from various parts of the world (Martinez 1999). 
The PFGE analysis also showed that there were wide variations among the 
strains of M. catarrhalis isolated from the same and different geographical 
location. However, strains isolated from same location showed some common 
bands shared by the strains. In conclusion, the study showed that the strains of M. 
catarrhalis may originate from ancestor strains and they have been proliferating 
with slow genomic rearrangement.  
 
 1.1.5.1 Colonization 
 M. catarrhalis is capable of colonizing humans without causing disease, 
which was one of the reasons it was characterized as a commensal bacterium. 
The rate of colonization is affected by age, health, socioeconomic condition, 
season and geographic location. M. catarrhalis is a frequent inhabitant of oro- 
and nasopharynx of children 0-10 years of age with a prevalence rate of 25-35%. 
Healthy adults are less frequently colonized (Ejlertsen 1991). In a study done on 
1520 patients (Ejlertsen 1994), M .catarrhalis colonization was examined with 
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respect to prevalence, time of colonization and association with respiratory tract 
infections (RTI). In the age group of 1-47 months, children with healthy 
respiratory tracts were colonized with a prevalence of 36%. However there was a 
significant increase in colonization rate in children with upper and lower RTI. 
 (68 %). Children with RTI may be prone to be colonized as long as their 
respiratory epithelium is damaged. Subsequently, they eliminate M .catarrhalis 
as they recover from their RTI, their colonization rate returning to the non-RTI 
children.  
Colonization with M .catarrhalis is not static. Molstad et al. (Molstad 1988) 
found a high rate of acquisition and elimination of M .catarrhalis in children. 
Nearly 100% of children in their study group were colonized at various times 
with a mean prevalence rate of 62%. 
 In the study of Chen et al (1999), they found that antibody levels against an 
OMP of M.catarrhalis (UspA1) are higher in 2 months old children when 
compared to 18 months old children due to the passage of maternal antibodies to 
the fetus during pregnancy. The low antibody levels and the low bactericidal 
activities seen in sera of children in 6-18 months of age are consistent with the 
epidemiological finding that children at this age have the highest rate of 
colonization and highest incidence of M. catarrhalis infection. 
 In a different study on nasophryngeal cultures from children of 0-2 years of 
age demonstrated that 66% of the infants become colonized within first year of 
life and increasing to 77.5% by two years of age (Faden 1994). This study also 
revealed that in the first 2 years of life a child acquires and clears 3 to 4 different 
strains of M. catarrhalis. Therefore, the rate of colonization in infants and young 
children is much more greater than that of adults. 
 
1.2 ADHERENCE: 
 
1.2.1 Definition and Importance 
 Bacterial adherence (also called attachment) is the term used to describe 
when bacteria attach to different types of surfaces present in the environment. 
Bacterial attachment is the initial step in the pathogenesis of infections. In M. 
catarrhalis, attachment to human pharyngeal epithelial cells (HPEC) has been 
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shown to be the initial event of infection (Mbaki 1987). Therefore studies on the 
attachment mechanism of M. catarrhalis is helpful for the understanding of 
pathogenesis as well as to find new strategies for the treatment and prevention of 
infection.  
 
1.2.2 Mechanism of Adherence 
 Several nonspecific factors are involved in the process of adhesion such as 
surface electric charge, hydrophobicity and van der Waals forces etc. It is 
important to note that these are initial factors; they are required, but not enough 
for firm binding. The specific factor for attachment is the interaction of the 
adhesin on the bacterium with the receptor on the host cell. Adhesin is a 
molecule on the surface of bacteria that mediates adherence by interacting with a 
receptor on the substratum. Chemically, adhesins may be proteins, 
polysaccharides, teichoic acids or lipids in nature. Many bacterial species have 
been found to express more than one type of adhesins and, in some cases, more 
than 10 have been described (London 1996). A receptor is any surface molecule 
of a substratum that is complementary to a bacterial adhesin. Chemically 
mammalian cell receptors are composed of proteins, glycoproteins and 
glycolipids.   
 Other factors to affect adherence are the seasonal changes (high in winter and 
low in summer), defects in immune system, repeated sub-culturing of bacteria in 
vitro, prior viral infection and underlying COPD (Rikitomi 1997, Rikitomi 1986).  
 Before the interaction of adhesin and the receptor, bacteria should overcome 
the repulsive electrostatic forces since both the bacterium and the epithelial cell 
are negatively charged. At this time point the filamentous structures such as 
fimbriae, flagella and fibrillae, act as bridging structures helping bacteria to 
overcome repulsion forces. The bacterium can now move closer to the surface of 
the epithelial cell, but the amount of water adsorbed around the surface of the 
epithelial cell or bacterium is the last barrier to overcome. Hydrophobic groups 
located on fimbriae or proteins of the cell surface, may play a major role, 
allowing the displacement of water molecules (Braga 2000). On the contrary, a 
recent study showed that bacteria with its negative charge bind with the 
positively charged micro domains (microplicae) on the HPEC. This study also 
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showed that HPEC is not entirely negatively charged rather composed of 
positively and negatively charged domains (Ahmed 2000). 
 
1.2.3 Mucus and Mucociliary Action 
 During a normal day a person inhales about 10,000 microorganisms per 24 
hours (Mims 1995). To prevent infection by this huge amount of 
microorganisms, mucosal surfaces have several mechanisms: 
• Secretion of mucus 
• Mucociliary clearance 
• Cellular defenses 
• Immunological defenses. 
 The mucus in the respiratory tract is a mixture of the secretions of different 
types of cells present in or under the mucosa: goblet cells, epithelial serous cells, 
secretory cells in submucosa and ciliated cells. It is a gel like structure consists of 
mucus glycoproteins  called mucins. It  acts as a barrier for microorganisms to 
overcome before reaching to the epithelial cell layer. Other functions of bronchial 
mucosa are to entrap microorganisms and repel them out of the respiratory tract 
by the mucociliary action. In addition, mucosa acts as an extracelullar surface for 
immunoglobulin action.  
 Some bacteria can produce factors that disturb the mucociliary system by 
slowing or disorganizing the beating of cilia (Wilson 1996). Some of these 
factors exert their effects by increasing the mucus production, which in turn, 
decrease the mucociliary action. Till now no such effect has been reported in M. 
catarrhalis. However, report has shown that M. catarrhalis can bind with human 
nasopharyngeal mucin (Reddy 1996). 
 
1.2.4 Adhesins and Receptors for M. catarrhalis  
 Adhesion is a complex process which might include more than one adhesin-
receptor interaction. For M. catarhalis, fimbriae are found to be adhesins. 
Fimbriae are composed of repeating subunits, the part that interacts with the host 
cell is on the tip of the pilus (London 1996). Other adhesins for M. catarrhalis 
are hemagglutinins, UspA1(Aebi 1988) and CD protein(Murphy 1993). In 
addition, in this study we proved that our protein of interest is an adhesin of M. 
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catarrhalis. The receptors for M. catarrhalis identified so far are ganglioside 
GM2 (Ahmed 1996) and asialoganglioside GM1 (Ahmed 2002).  
 
1.2.5 How to Exploit Adherence 
 The study on bacterial adherence to host is not only a basic science to 
understand the pathogenesis and virulence factors, but also it has several practical 
applications. These applications center on the prevention of adhesion before or 
after the bacterium attaches to host. One of them is to provide the adhesin or its 
analogue into the respiratory tract. This might be done by spraying it to the 
pharynx of the patient. The adhesin or its analogue will bind to complementary 
receptor on host cells. This will block the receptor and will prevent the 
attachment of bacteria to the epithelial cells. The same logic can also work for the 
receptor. There are receptor analogs, which can mimic the receptor and bind to 
the adhesin on the surface of bacterium. The binding of the receptor analog to the 
adhesin will block the adhesin-receptor interaction.  
 Another strategy is to use the adhesin as a vaccine. Since it is a surface 
protein, the immune response primed by adhesin, would be protective. The 
immune system will not only act by conventional means to kill the bacterium, but 
also prevent the adherence by the binding of antibodies to adhesin.  
 The scope of adhesion research can be enlarged by using anti-attachment 
drugs. These can be divided into two: 
1. Low-dose antibiotics. 
2. Non-antibiotic drugs.  
 Low-dose antibiotics don’t kill the bacteria but prevent the attachment by 
changing the surface structure of the bacterium. But the weakness of this strategy 
is the rapid emergence of the antibiotic resistant bacteria. 
 The non-antibiotic drugs have the ability to prevent attachment of M. 
catarrhalis and nontypeable H. influenzae. One of them is a widely used 
mucolytic drug: S-carboxymethyl cysteine(S-CMC). The mechanism how S-
CMC prevent attachment is not yet clear, however, it has been shown that it can 
remove the carbohydrate from the surface of HPEC (Zheng 1999). The receptors 
for bacteria are mainly glycolipid in nature therefore it is thought that S-CMC 
may remove the receptor from cell surface. Another study showed that S-CMC 
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can decrease the positive charge of the microplicae hence decrease the attraction 
needed for bacteria to attach with  HPEC (Ndour 2001). 
 
1.3 Aim of the Project 
  The aim of this project can be categorized as the following: 
1. Isolation of an adhesin from the surface of M. catarrhalis. 
2. To understand the biochemical properties of the protein such as heat 
sensitivity, molecular weight, sensitivity to reducing agents and 
glycosylation.  
3. To determine the immunogenic potential of the protein: 
a. In animal by inoculating bacteria 
b. In human during M. catarrhalis infection 
4. Production of monoclonal antibody 
5. Attachment inhibition assay to prove the protein as an adhesin. 
6. N-terminal amino acid sequence. 
7. Identification of the gene of the protein 
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CHAPTER 2:  MATERIALS AND METHODS 
 
2.1 MATERIALS 
 
2.1.1 Chemicals 
 All chemicals were of analytical grade and supplied by Sigma-Aldrich 
Chemie GmbH (Germany) except for: 
• 4-chloro-1-naphthol was purchased from Wako Pure Chemical Industries Ltd. 
(Japan). 
• Ampicillin and kanamycin were purchased from Roche Diagnostics GmbH 
(Germany). 
• IPTG, X-Gal were purchased from MBI Fermentas Inc. (USA). 
2.1.2. Bacterial Strains  
 In this study, for all purposes M. catarrhalis was used and only for cloning 
purposes E. coli was used. 
2.1.2.1 E. coli Strains 
Strain Genotype   Usage    Source  
M15 F-,NalS,StrS,rif8,lac-,ara-,gal- Production of expression  Bio-Rad
  mtl-,rec+,uvr+   libraries   (Hercules
           USA) 
DH5α     F-supE44 hsdR17 recA1gyrA96   Production of library Bio-Rad 
        endA1 thi-1 relA1 deoR lsmbda-  and propagation of plasmids (Hercules
          ,USA) 
     
 
 
 
2.1.2.2  M. catarrhalis strains 
 Strains of M. catarrhalis, B-87-34, B-87-69, B-87-94, B-88-152 and strain F 
isolated from sputum of patients with RTI were used in this study.  Strain B-88-
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152 was mainly used unless otherwise stated. Except strain F, all the strains were 
fimbriated (Ahmed 1990). 
 
2.1.3 Enzymes 
 All restriction enymes (HindIII, PstI, and EcoRV), DNA modifying enzymes 
(T4 ligase, calf intestine alkaline phosphatase) and Taq polymerase were 
purchased from MBI Fermentas Inc. (USA). RNase A, Proteinase K and  
Lysozyme were purchased  from Roche Diagnostics GmbH (Germany). Lysine 
endopeptidase was purchased from Wako Pure Chemical Industries Ltd. (Japan). 
  
2.1.4 Oligonucleotides 
 All primers used in this study were custom synthesized and purchased  from 
Iontek (Bursa, Turkey). The sequences of the primers were designed by 
converting the N-terminal amino acid sequence of 55 kDa protein to DNA 
sequence. These primers were used to amplify possible gene of 55 kDa protein 
by PCR for sequencing. The sequences of the primers were as follows: 
Forward: 5’-ATTACTCATCAAAATATGCTTCC-3’ 
3rd   base is degenerate: T, C or A 
6th  base is degenerate: T, C, A or G 
9th base is degenerate: T or C 
12th base is degenerate: A or G 
15th base is degenerate T or C 
19th base is degenerate: T or C 
21st base is degenerate: T, C, A or G 
 
Reverse:  5’- TTAGCAGGAAACATATTTTGATG- 3’ 
3rd base is degenerate: T, C, A or G 
6th base is degenerate: T, C, A or G 
9th base is degenerate: T, C, A or G 
11th base is degenerate: A or G 
15th  base is degenerate: A or G 
18th base is degenerate: T or C 
21st base is degenerate: A or G 
  
 Apart from these degenerate primers, a 23-mer oligonucleotide has been 
designed according to the preferred codon usage in gram-negative bacteria. This 
oligonucleotide was used in colony hybridization experiment as the radiolabelled 
probe. 
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Probe: 5’- AAAATCCAYACCCCGAGCATCAC-3’ 
Y= C or T 
 We also used several primers for sequencing purposes which are not shown 
here for limitation of space.  
 
2.1.5 Cloning Vectors 
 pQE-31 (Qiagen Inc. USA) and pBluescript SK (Stratagene Inc. USA) were 
the vectors used in this study.  
 
Figure 2.1: The map of pQE expression vector. It contains lac operon and 
is suitable for expression studies. 
 
Figure 2.2:  The map of pBluescript cloning vector. It contains lacZ gene 
and suitable for α-complementation 
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2.1.6 Antibodies 
 The primary antibodies used in this study were the monoclonal antibody 
against 55 kDa protein and polyclonal antibody against whole cell M. catarrhalis. 
2.1.6.1 Generation of monoclonal antibody against 55 kDa protein 
 mAb 4H3, a murine antibody of IgM class (Hybridoma Subisotyping Kit, 
Calbiochem-Novabiochem Corporation, USA), was prepared by fusing spleen 
cells from BALB/c mouse immunized with 55 kDa protein with SP-2 mouse 
myeloma fusion partner (Oishi 1996) and screening the resulting hybridomas by 
enzyme-linked immunosorbent assay (ELISA) employing microtiter wells coated 
with 55 kDa protein. mAb to 55 kDa protein was measured in polystyrene 
microtiter plate caoted with 1 µg of purified protein per ml suspended in coating 
buffer and left to stand overnight. mAb 4H3 was cloned and adapted as an ascites 
tumor in pristine-primed BALB/c mice. Ascitic fluid was collected, centrifuged 
and the supernatant was stored at -80 °C until use.  
   
2.1.6.2 Generation of polyclonal antibody against M. catarrhalis 
 Whole cell antibody against strain B-88-152 was generated by injecting a 
rabbit with live organism as described previously (Ahmed 1992). A dose of 1 ml 
bacterial suspension in 1 ml Freund’s adjuvant (Difco Laboratories, USA) was 
injected each time in equally dividing doses into two subcutaneous and two 
intramuscular sites. A total of four doses was administered at 2-week intervals. 
Two weeks after the last injection, blood was collected and the serum was stored 
at -80 °C.  
 
2.1.6.3 Secondary Antibodies  
 Secondary antibody for colony lift, dot blot and Western blotting was 
purchased from Sigma (Sigma-Aldrich Chemie GmbH Germany). It was anti-
mouse IgM antibody conjugated to horse radish peroxidase (HRP) enzyme to 
permit the visualization of the signals. The secondary antibody for 
immunofluorescence was purchased from Zymed (Zymed Laboratories, Inc., 
USA). It was goat anti-mouse IgM antibody conjugated to fluorscein 
isothiocyanate (FITC).   Secondary antibodies for sputum Western blot were anti-
human IgA, IgG and IgM conjugated with HRP. The secondary antibody for 
 17 
rabbit antiserum experiment was anti-Rabbit IgG conjugated with HRP and it 
was purchased from Zymed. 
 
 
2.1.7  Commercially Available Kits 
 Qiaex II Gel Extraction Kit (by Qiagen Inc., USA) was used to purify DNA  
from agarose gels.  
 MN Nucleospin Plasmid (Macherey-Nagel, GmbH& Co, Germany) was used 
to purify plasmids from E. coli. 
 DIG Glycan Detection Kit (Boehringer Mannheim Corp. USA) was used to 
determine the gycosylation status of proteins.  
HexaLabel Plus DNA Labeling Kit (MBI Fermentas Inc. NY, USA) was used 
to radioactively label the oligonucleotide probe for colony hybridization 
experiment. 
Silver Stain Kit (Wako Pure Chemical Industries Ltd. Japan) was used to stain 
the SDS-PAGE gels.  
Mouse IgM LL Nanorid Kit (Binding Site Limited, England) was used to 
determine the concentration of the primary antibody.  
 Hybridoma Serotyping Kit (Calbiochem –Novabiochem  Corporation, USA) 
was used to determine the class of the antibody produced. 
 DYEnamic ET Terminator Cycle Sequencing Kit (Amersham Biosciences UK 
Limited, England) was used for sequencing reactions. 
 Bio Rad Protein Assay Kit ( Bio Rad Laboratories, USA) was used to 
determine concentration of proteins. 
 
2.1.8 Apparatus and Equipment 
 Vertical mini gel apparatus for polyacrylamide gel electrophoresis was a 
product of Atto Corp. (Japan). The power supply was Power Pac 200 from Bio 
Rad Laboratories (USA). Horizontal mini gel apparatus used for agarose gel 
electrophoresis was Mupid-2 purchased from Advance Co., Ltd., Japan. Thermal 
cycler for PCR was a product of Perkin Elmer (USA). Slab gel dryer is from 
Savant Instruments Inc. (USA). Wet  transfer unit for Western Blotting and 
GelDoc 2000Image analyzer for agarose gel electrophoresis were purchased from 
Bio Rad Laboratories (USA). Cytospin for attachment assays was purchased 
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from ThermoShandon Inc. (USA). UV cross linker, the UV Stratalinker 1800, 
was from Stratagene Inc (USA).  Fluorescence microscope was from Zeiss (Carl 
Zeiss Jena GmbH, Germany) 
 
 
 
2.1.9 Materials for Autoradiography 
 Radiolabelled dCTP (containing 32P) was purchased from NEN ( NEN Life 
Science Products, Inc. USA) The light-proof film cassette (Hypercassette) and 
film developing unit were products of Amersham Biosciences UK Limited 
(England) Medical x-ray films were purchased from Fuji (Tokyo, Japan). 
 
2.1.10 DNA and Protein Size Markers 
 As DNA size marker 1 kb DNA ladder from MBI FERMENTAS Inc. (USA) 
was used.  
 SDS-PAGE protein size markers, the Rainbow Marker and Low Range 
Protein Size Marker were purcahsed from Bio Rad Laboratories (CA, USA). 
 
2.1.10 Membranes 
 Nitrocellulose membranes for colony lift and colony hybridization were 
purchased from Shleicher & Schuell GmbH (Germany) 
 PVDF membranes for Western blots were purchased from Bio Rad 
Laboratories (USA) 
 
2.1.11 Computer Programs 
 DNASIS Mac V3.6 and Oligo 4.0s were used to design oligonucleotide 
primers.  
GENETYX-MAC 10.1 was used to translate the DNA sequence into amino acid 
sequence in three reading frames. Pairwise BLAST and protein BLAST was used 
for homology search. 
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2.2 SOLUTIONS AND MEDIA 
2.2.1  Agarose Gel Electrophoresis Solutions 
50X Tris-Acetic acid-EDTA (TAE) Per Liter: 242 g Tris Base 
      57.1 ml Glacial Acetic acid 
      100 ml of 0.5 M EDTA 
 
 
Ethidium bromide    10 mg/ml in water (stock solution) 
      30 ng/ml(working solution) 
 
 
2.2.2 Microbiological Media and Antibiotics 
 
Luria-Bertani Medium(LB)  Per Liter: 10 g Bacto tryptone,  
      5 g Yeast extract 
      5 g NaCl 
      15 g Agar(for solid media) 
 
Blood Agar    %7 Rabbit blood in BHI agar 
 
 
Brain Heart Infusion (BHI) Agar  Per Liter: 52 g of BHI agar powder  
 
BHI Broth     Per Liter: 37 g of BHI broth powder 
     
 
 
Mueller Hinton (MH) Broth  Per Liter:21 g of MHB powder 
    
 
 
Ampicillin     100 mg/ml(stock solution)  
      100 µg/ml (working solution) in dH2O 
 
 
Kanamycin     25 mg/ml (stock solution) 
      25 µg/ml (working solution) in dH2 
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2.2.3 Polyacrylamide Gel Electrophoresis Solutions 
 
Separating Gel (10%)   7.8 ml dH2O 
      5 ml 1.5 M Tris(pH 8.8) 
      6.7 ml acylamide-bisacrylamide(30:0.8) 
      200 µl 10% SDS 
      200 µl 10% APS 
      6.7 µl TEMED  
 
Stacking Gel (5 %)   3.3 ml dH2O 
      1.5 ml 0.5 M Tris(pH 6.8) 
      1 ml acylamide-bisacrylamide(30:0.8) 
      60 µl 10% SDS 
      120 µl 10% APS 
      3 µl TEMED  
 
Sample Buffer    10 ml 10 % SDS 
      4 ml 0.25 M Tris-HCl (pH 7.6) 
      6 ml dH2O 
      2 ml Glycerol 
      30 mg EDTA.2Na 
     and per ml of the above solution: 
20 µl Bromophenol Blue 
 (Saturated Soln)/ml 
      75 µl 2-mercaptoethanol OR 
      0.13 g of DTT/ml 
 
Electrophoresis Buffer(10X)  Per 500 ml:15.14 g Tris 
      72 g Glycine 
      5 g SDS 
 
Staining Solution    2 g Coomassie Blue   
       100 ml Trichloro acetic acid (100%)  
      400 ml Ethanol 
      500 ml dH2O 
 
Destaining Solution   1950 ml dH2O 
      750 ml Ethanol 
      240  ml Acetic Acid    
 
2.2.4 Colony Lift Solutions 
 
10X TBS     Per Liter: 80 g NaCl 
      2 g KCl 
      30 g Tris(pH 8.0) 
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Blocking Solution    5% non-fat dry milk or 5% BSA 
 
2.2.5 Western Blot Solutions 
 
10X Tris-HCl Buffer   Per Liter: 12.4 g Tris-HCl (pH 7.3) 
      85 g NaCl 
 
Electrode Solution   Per Liter: 6 g Tris 
      28.8 g Glycine 
      600 ml Methanol 
 
Blocking Solution    5% non-fat dry milk 
       
 
2.2.6 Colony Hybridization Solutions  
 
Denaturation solution   0.5 NaOH 
      1.5M NaCl 
      0.1% SDS 
 
Neutralization Solution   1.0 M Tris-HCl, pH 7.5 
      1.5 M NaCl 
 
20X SSC     3M NaCl 
      0.3M Sodium Citrate, pH7.0 
 
Blocking Solution    0.5M Sodium Phosphate Buffer, pH7.0 
      7% SDS 
      1mM EDTA  
 
2X Wash Solution    2X SSC 
      0.1% SDS 
 
0.1X Wash Solution   0.1X SSC 
      0.1% SDS 
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2.3 METHODS: 
 
2.3.1 Growth and Maintenance of Bacteria 
 
2.3.1.1 M. catarrhalis 
 M. catarrhalis strains were  stocked in MH broth containing 5% rabbit blood 
and stored at -20C until use. For stocking, the bacteria were cultured on 7% 
rabbit blood agar plates and the colonies were taken with a sterile cotton swab 
and transferred to the cryotube containing 1 ml of media. During experiments, 
the bacteria were cultured on BHI agar or BHI broth. The plates were incubated 
in a box containing 5% CO2 at 37 °C. The CO2 was generated by the CO2 Gen 
Compact (Oxoid Limited, UK). All media were purchased from Merck Kga, 
(Germany). 
 
2.3.1.2  E. coli 
 E. coli strains were stored in 50% sterile glycerol at -70 °C until use. 
Overnight grown cultures to saturation were mixed with sterile glycerol in a ratio 
of 1:1, mixed to homogeneity and stored at -70 °C until required. Bacteria were 
recovered by scraping a small amount of cells from the stock with an inoculation 
loop and streaking onto a LB-agar plate. Experiments with E. coli were done by 
culturing the bacteria on LB agar or LB broth. Liquid cultures were incubated in 
a rotary shaking incubator at 37 °C (~200 rpm). 
  
2.3.2 DNA EXPERIMENTS 
 
2.3.2.1 Preparation of Competent Cells and Transformation of E. coli 
 
2.3.2.1.1 Simple and Efficient Method (SEM) for Preparation of 
Competent Cells 
 A single colony of appropriate E. coli strain was inoculated into 15 ml of LB 
broth (containing the appropriate antibiotics) and grown overnight at 37 °C. The 
starter culture was diluted to OD600 of 0.2-0.3 in 250 ml of SOB medium (2% 
Bacto-tryptone, 0.5 % yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 
10 mM MgSO4, sterilized by autoclaving) and grown to an OD600 of 0.6 at 18 °C 
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with shaking at 200-250 rpm. The culture was chilled on ice for 10 minutes, 
centrifuged at 2500 Xg for 10 minutes at 4 °C. The pellet was then resuspended 
in 80 ml of ice-cold TB (10mM Pipes, 55mM MnCl2, 15mM CaCl2, 250mM 
KCl, pH 6.7, sterilized by filtration through 0.45µm filter, stored at 4 °C ), and 
incubated on ice for 10 minutes. The mixture was pelleted as above, resuspended 
gently in 20 ml of TB. DMSO was added to a final concentration of 7%, mixed 
gently and incubated on ice for 10 minutes. Aliquots of this mixture were then 
immediately chilled in liquid nitrogen, and stored at -70 °C up to 3 months 
without loss of transformation efficiency (Inoue et al. 1990). 
 
2.3.2.1.2. Transformation of E. coli  
 For transformation using supercompetent cells, an aliquot of frozen 
competent cells was thawed on ice. 200 µl of the cells was mixed with plasmid 
DNA (less then 100ng) in an eppendorf tube and incubated on ice for 30 minutes. 
The cells were then exposed to a 90 seconds heat-shock at 42 °C and then chilled 
on ice for 2 minutes. 800 µl of SOC (SOB with 20mM glucose) was added and 
the cells were grown at 37 °C for 45 minutes with vigorous shaking at 250 rpm. 
The culture was then centrifuged and the pellet was resuspended in 100µl of 
SOC, and spreaded on LB agar plates containing the appropriate antibiotic.  
 
2.3.2.2 Plasmid DNA Isolation 
 The plasmid DNA was isolated with MN Nucleospin Plasmid  kit according 
to the manufacturers instructions.  
 
2.3.2.3 DNA Ligation Reactions 
 DNA fragments were ligated into plasmid vectors in 15 µl reaction volumes 
containing 0.3-1.0 µg of linearized plasmid vector and 3-5 times molar excess of 
insert DNA in the presence of 1-4 Weiss units of T4 ligase and 1 X concentration 
of the standard ligation buffer supplied with the enzyme. The reaction mixture 
was incubated at 16 °C for overnight. 
 
2.3.2.4  Restriction Enzyme Digestion 
 Restriction enzyme digestions were performed in 10-20 µl reaction volume 
for 1.5 to 4 hours and typically 1-10 µg of DNA and 5-15 units of restriction 
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enzymes were used. Reactions were carried out with the appropriate reaction 
buffer and conditions according to the manufacturers recommendations.  
 
2.3.2.5 Alkaline Phosphatase Reaction 
 Calf intestine alkaline phosphatase enzyme was used in order to prevent the 
religation of the linearized plasmids in the ligation reaction. In 50 µl of total 
volume, 1 µl of enzyme and 5 µl reaction buffer was used to remove phosphates 
from DNA.  
 
2.3.2.6 Polymerase Chain Reaction 
 Polymerase chain reaction (PCR) was performed to amplify and sequence the 
possible gene encoding 55 kDa protein. PCR reactions were performed in 
ThermowellTM tubes (Corning Costar Corp.) using GeneAmp PCR system 9600 
(Perkin Elmer). 
 PCR reactions were carried out in a reaction volume of 50 µl containing 100 
ng of M. catarrhalis genomic DNA, 5 µl 10X PCR buffer, 4 mM MgCl2, 0.32 
mM of each dNTP 20 pmol of each primer and 2.5 unit Taq DNA polymerase.  
 The reaction mixture was preheated to 94 °C for 5 minutes and subjected to 
30 cycles of denaturation (30 seconds at 94 °C), annealing (45 seconds at 55 °C) 
and elongation (2 minutes at 72 °C). At the end of the 30 cycles a final extension 
at 72 °C for 10 minutes was also applied. PCR products were assessed by agarose 
gel electrophoresis and EtBr staining.  
 
2.3.2.7 Genomic DNA Isolation from M. catarrhalis 
 Large scale genomic DNA isolation was performed by the standard methods 
of  Current Protocols (John & Wiley press 1998)for gram-negative bacteria.  
 100 ml BHI broth was inoculated with 1 or 2 colonies of M. catarrhalis. 
After overnight incubation the bacteria were harvested by centrifugation at 10000 
rpm. The pellet was resuspended in 8.75 ml of 10X TE (100mM Tris-HCl, pH 
7.5, 10 mM EDTA) by repeated pipetting and then transferred to a disposable 50 
ml centritube. The cell suspension was freezed at -20 °C for 60 minutes. 1.0 ml 
of freshly prepared lysozyme(10 mg/ml in 0.25 Tris-HCl, pH 8.0) solution was 
added to the frozen cells and the cells were thawed by mixing in a room-
temperature water bath. Just after thawing, the cells were put on ice for 45 
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minutes. 0.25 ml of 20 % SDS, 50µl of 20 mg/ml proteinase K and 10 µl of 10 
mg/ml DNase-free RNase was added to the cell suspension. After mixing 
thoroughly the solution was incubated at 55 °C for 1 hour with occasional gentle 
mixing. Then 1.8 ml of 5 M NaCl was added and the tube was mixed thoroughly 
by inverting for 5 minutes. 1.5 ml of CTAB/NaCl solution was added and the 
tube was mixed thoroughly and then it was  incubated at 65 C for 20 minutes 
with occasional shaking. 
  Approximately equal volume of chloroform: isoamyl alcohol (49:1) was 
added, the tube was mixed thoroughly by inverting the tube for 5 minutes, and it 
was spin down 10 min at 3000 rpm. The chloroform phase was removed and the 
supernatant and the interphase were homogenized with a plastic pipette. The 
suspension was centrifuged 10 min at 3000 rpm again and the aqueous, viscous 
supernatant was transferred to a fresh centritube, leaving the interface behind.  
  An equal volume of phenol:chloroform:isoamyl alcohol (25:24:1), was added 
and the solution was extracted thoroughly by inverting the tube and was 
centrifuged 10 minutes at 3000 rpm. The aqueous, viscous supernatant was 
transferred to a fresh centritube, leaving the interface behind.  
 0.6 volume of isopropanol was added to precipitate the nucleic acids. The 
DNA pellet was transferred to a fresh tube containing 70 % ethanol by hooking it 
onto the end of a glass Pasteur pipette. The DNA was washed with 70 % ethanol 
to remove the residual CTAB and recentrifuged to pellet it. The supernatant was 
removed carefully and the pellet was dissolved in TE.  
 
2.3.2.8 Phenol-Chloroform Extraction 
 Phenol-chloroform extraction was done to purify DNA after each enzymatic 
manipulation. First, an equal volume of phenol:chloroform:isoamyl alcohol 
(25:24:1) was added to the DNA solution containing the impurities. The optimum 
starting volume was about 100 µl. If the solution was less than this volume it was 
diluted with dH2O accordingly. After mixing 45 seconds by vortexing, the tube 
was centrifuged for 5 minutes at 13000 rpm. The upper (water phase) was 
transferred to a new eppendorf tube . Then 1/10 volume of 3M NaOAc was 
added.  After mixing by inverting the tube 2.5 volume of cold absolute ethanol 
was added. After mixing by inverting the tube was kept in -80C for 20 minutes. 
Then the tube was centrifuged for 10 minutes at 13000 rpm. After discarding the 
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supernatant, the pellet was washed with 200 µl of 70% ethanol. After drying all 
the ethanol the pellet was dissolved in TE or water.  
 
2.3.2.9 Electroelution 
 This method was done to purify DNA from agarose gels that were too big for 
Qiagen Gel Extraction kit. First, the DNA was electrophoresed by using freshly 
prepared TAE buffer. Using the long wavelength UV the band was located and 
cut with a scalpel. The gel slice was put in the dialysis membrane containing 
some TAE. Then the membrane was put in the electrophoresis tank and run for 1 
hour at 150 V. The electric field was reverted for 10 seconds. Then the buffer 
containing the DNA was taken out with a Pasteur pipette and the membrane was 
washed with 300 µl TE buffer.  
 
2.3.2.10 Butanol Concentration 
 High volume DNA solution obtained after electroelution was concentrated 
using this method. Equal volume of butanol was added to DNA solution. After 
vortexing for 10 seconds the tube was centrifuged for 15 seconds. The upper 
butanol phase was discarded. This process was repeated until desired volume was 
reached.  
 
2.3.2.11 Agarose Gel Electrophoresis 
  DNA fragments of less than 1 kb were generally separated on 1.0 % agarose 
gel , those greater than 1 kb were separated on 0.8 % gels. Required amount of 
agarose gels were completely dissolved in 1X TAE buffer by heating in 
microwave, then ethidium bromide was added to a final concentration of 30 
ng/ml. The DNA samples were mixed with one volume loading buffer and loaded 
onto gels. The gel was run at room temperature in 1X TAE at 100 V. 
 
2.3.2.12 Purification of Linear Plasmid DNA from Agarose Gels 
 This method was used to isolate the linear plasmid from the restriction 
enzyme digested plasmid DNA that contained both linear and circular bands. For 
this experiment Qiagen Gel Extraction Kit was used. The instructions of the 
manufacturer were pursued. 
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2.3.2.13 DNA Sequence Analysis 
 DNA sequence analysis of the positive clones was performed by the 
dideoxy method. Cycle sequencing reactions were set up in 0.2 ml Greiner tubes. 
The 20 µl reaction volume contained 30-180 ng template miniprep plasmid 
product, 3.2 pmol of primer and 8 µl terminator ready reaction mix (DYEnamic 
ET Terminator Cycle Sequencing Kit, Amersham Biosciences UK Limited, 
England). The cycle sequenase reactions were performed in Perkin Elmer 
GeneAmp PCR 9600 system thermal cycler with the following parameters: 25 
cycles of denaturation (95 °C for 20 seconds), annealing (50 °C for 15 seconds) 
and extension (60 °C for 1 minutes).  
 Electrophoresis was performed on the ABI PRISMTM 377 Genetic Analyzer 
(Perkin Elmer, USA) by loading the samples into the lanes of a vertical 
polyacrylamide slab gel. The separated DNA fragments were exposed to a laser 
which in turn would excite the flourescent dyes attached to the fragments. These 
data were then collected and analyzed by the help of ABI Sequencing Analysis 
Software (version 3.0.1). 
 
2.3.3 PROTEIN EXPERIMENTS 
 
2.3.3.1 Isolation of 55 kDa Protein 
 Celite chromatography was done to isolate the 55 kDa protein with the 
procedure described previously (Lu 1998). 1 g of activated celite was suspended 
in 100 mM Tris-buffered saline, pH 7.6 (TBS) and added to the column.  
Surface proteins from bacteria were harvested by water extraction as described 
previously (Pei 1988). The water extract (WE) in 1 mM phenylmethylsulphonyl 
flouride at 4 °C was applied on the matrix at a flow rate of 0.5 ml/minute. The 
column was washed with 100 ml 100 mM TBS to remove unbound proteins. 
Bound protein was eluted with 10 ml stepwise gradient of 5~10 mM EDTA and 
finally with 1M Tris, pH 10.5. 
 Eluted fractions were checked by spectrophotometer (OD280) to determine the 
presence of protein. Finally, the protein elution was confirmed by running the 
elutions on SDS-polyacrylamide gels. Protein concentration was determined by 
Bio Rad Protein Assay Kit according to the manufacturer’s instructions. 
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2.3.3.2 N-Terminal Amino Acid Sequencing 
  The single eluted protein was sequenced by directly applying protein through 
automated N-terminal Edman degradation with the High Performance Liquid 
Chromatography  system.  For determination of N-terminal amino acid sequence 
of 55 kDa protein fragments, the protein was dialyzed against dH2O for 
overnight, then lyophilized. The protein was dissolved in 300 ml of 0.1 M 
NH4HCO3, then 20 ml, 1 mg/ml of lysine endopeptidase was added and 
incubated at 37 °C in an incubator for 4 hours. 15 ml of the product was applied 
onto a C4 column and eluted with graded concentration (0-70%) of  acetonitrile 
at a flow rate of 1 ml/min. Elutions were collected at peak. The two highest peaks 
were subjected to N-terminal sequencing. 
 
2.3.3.3 Glycan Detection 
 DIG Glycan Detection Kit was used to determine whether our protein was 
glycosylated or not. Adjacent hydroxyl groups in sugars of glycoconjugates are 
oxidized to aldehyde groups by mild periodate treatment. The spacer linker 
steroid hapten digoxigenin (DIG) is then covalently attached to these aldehydes 
via a hydrazide group. DIG labelled glycoconjugates are subsequently detected in 
an enzyme immunoassay using a digoxigenin specific antibody conjugated with 
alkaline phosphatase.  
 The 55 kDa protein, transferrin and creatinase (5µg/lane) was subjected to 
SDS-PAGE. After transferring to PVDF membrane, the protocol was followed 
according to the instruction of the manufacturer. 
 
2.3.3.4 SDS Polyacrylamide Gel Electrophoresis and Western Blot 
 Electrophoretic separation of proteins under denaturing conditions was 
performed by using the vertical mini gel apparatus. For all experiments 5 % 
stacking gel and 10% separating gel was used and run at 40 mA. After 
performing SDS-PAGE, the proteins were transferred from the gel to 
nitrocellulose or PVDF membrane at 100 V for 1 hour. Membranes were blocked 
by 5 % non-fat dry milk or BSA.  For detection of the transferred proteins, 4-
chloro-1-naphthol method was used (explained in section 2.3.3.5). 
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2.3.3.5 Colony Lift 
 This method was used to detect the bacteria expressing the protein of interest 
on their surfaces. Firstly the bacteria were streaked or spreaded on LB agar plates 
containing the appropriate antibiotic(s).  The membrane was placed onto the plate 
for 1minute to lift the colonies and was incubated in petri dish containing 10 ml 
5% non-fat dry milk (in TBS) for overnight at 4 °C. Then the membrane was 
washed 3 times with TBS each time for 3 minutes in a rotary shaker. Then the 
membrane was treated with primary antibody for 90 minutes  at a dilution of 
1:5000 (0.1 µg/ml) and was washed 3 times with TBS. After the washing step, 
the membrane was treated for 90 minutes with secondary antibody at a dilution of 
1:5000 in TBS. Then the membrane was washed again 3 times with TBS. The 
detection part of the experiment was done in two different ways: 
1. By using ECL reagents: The ECL reagents were mixed and spreaded over 
the membrane for 1 minute. The film was exposed to the membrane for 1 
minute. Then the film was developed in a (name company of the 
machine) 
2. By using 4-chloro-1-naphthol: Solution A (15 mg 4-chloro-1-naphtol in 5 
ml cold methanol) and Solution B(15 µl 30% H2O2 in 20 ml Tris-HCl) 
were prepared. A and B were mixed and the solution was incubated with 
the membranes  until the color reaction was seen.  
 
2.3.3.6 Dot Blot 
 This method was used to confirm the positive signals obtained in the colony 
lift protocol. 2-3 colonies were picked up from the LB agar and suspended in 
TBS. 2-3 drops of this suspension were given on to the nitrocellulose membrane. 
After drying the membrane the procedure was followed as described in colony 
lift.  
 
2.3.3.7 Attachment Inhibition Assay 
 Attachment assay is used to measure the attachment ability of bacterial cells 
to the human pharyngeal epithelial cells. In attachment inhibition assay, whether 
a molecule can prevent attachment of bacteria to human pharyngeal epithelial 
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cells is determined. In this study, 2 types of attachment inhibition assays were 
done:  
1. Attachment inhibition assay with protein 
2. Attachment inhibition assay with antibody.  
 In the first type of attachment experiment, the 55 kDa protein was incubated 
with the pharyngeal epithelial cells. If the protein was an adhesin as we 
hypothesized, the exogenously added 55 kDa protein would bind and block the 
receptor on the epithelial cell and attachment of bacteria would decrease with 
respect to control. In the second type of attachment experiment, the mAb against 
55 kDa protein was incubated with M. catarrhalis. If the protein was an adhesin 
as we hypothesized, the antibody would bind and block the 55 kDa protein on M. 
catarrhalis and attachment of bacteria would decrease with respect to the control. 
 
 
2.3.3.7.1 Attachment Inhibition Assay with 55 kDa Protein 
 Attachment inhibition assay was performed as described previously (Ahmed 
1996). Pharyngeal epithelial cells were taken from the throat of a healthy adult 
individual by scraping the oropharynx with a sterile cotton swab. The cells were 
transferred to 1/15 mM phosphate buffer pH 7.2 (PB) and filtered to remove 
particles. Then in order to get rid of the normal flora that might interfere with the 
attachment, the cells were washed 3 times with PB each time for 10 minutes by 
centrifugation at 80 Xg at room temperature. The number of cells were 
determined by Neubauer counting chamber and adjusted to a concentration of 
2.5X 104 cell/ml. 
 Then cells were treated with the 55 kDa protein in a shaking water bath at 37 
°C for 30 minutes. Cells without 55 kDa protein treatment was taken as a control. 
Overnight grown M. catarrhalis was suspended in phosphate buffered saline pH 
7.2 (PBS) and adjusted to a concentration of 1X 108 cfu/ml by 
spectrophotometer. Then the cells and the bacteria were mixed in a 1:1 ratio and 
centrifuged at 750 Xg for 10 minutes at room temperature and incubated for 30 
minutes at 37 °C.  After the incubation, 5 times washing was done with PBS to 
remove the unattached bacteria. The cells in the suspension, then,  collected on a 
slide with cytospin. The slides were Gram stained and the attached bacteria were 
counted by observing 50 consecutive cells under an oil immersion objective.  We 
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also similarly performed attachment inhibition assay with exogenously added 
BSA to rule out nonspecific effect on attachment inhibition by 55 kDa protein. 
 
2.3.3.7.2 Attachment Inhibition Assay with Antibody Against 55 kDa 
protein 
 Pharyngeal epithelial cells were collected and adjusted to a concentration of 
2.5 X 104 cells/ml as described above. Overnight grown M. catarrhalis was 
suspended in PBS and adjusted to a concentration of 1X 108 cfu/ml by 
spectrophotometer. Then bacteria were treated with antibody in a shaking water 
bath at 37 °C for 30 minutes. Bacteria treated in the same way without any 
antibodies were taken as control. Then the attachment assay was done as 
described above. We also similarly performed attachment inhibition assay with 
exogenously added unrelated mouse IgM to rule out nonspecific effect on the 
attachment inhibition by mAb against 55 kDa protein. 
 
2.3.3.8 Quantitative Culture 
 This method was used to calculate the M. catarrhalis number via 
spectrophotometric measurement. M. catarrhalis colonies grown on BHI agar 
were suspended in PBS in different dilutions. After measuring the turbidity of 
these suspensions by a spectrophotometer (OD660), the bacteria were enumerated 
by quantitative culture. This was done by constructing a calibration curve, which 
made possible the determination of number of viable bacteria from A660 readings.  
  
 
2.3.3.9 Radial Immunodiffusion (RID) 
 Radial immunodiffusion is a technique that is routinely used for measuring 
the concentrations of various soluble antigens. The method involves antigen 
dissolving radially from a cylindrical well through an agarose gel containing an 
appropriate mono-specific antibody. Antigen-antibody complexes are formed, 
which under the right conditions, will form a precipitin ring. The ring size will 
increase until equilibrium is reached between the formation and break down of 
these complexes. At this stage, a linear relationship exists between the square of 
ring diameter and the antigen concentration. By measuring the ring diameters 
produced by a number of samples of known concentration, a calibration curve 
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can be constructed. The concentration of an antigen in an unknown sample may 
then be determined  by measuring the ring diameter produced by that sample and 
reading of the calibration curve. 
 In this study, the radial immundiffusion was performed for determination of 
mAb concentration in ascitic fluid by Mouse IgM LL Nanorid Kit.  
 
2.3.3.10 Colony Hybridization 
 This method was used to screen the genomic DNA library of M. catarrhalis 
with radioactively labeled oligonucleotide probe. First, the plates of E. coli 
containing the genomic library were chilled at 4 °C for 1 hour. After that, 
nitrocellulose membranes were exposed to the colonies for 1 minute and labeled 
properly, A blotting paper (Whatmann) was put into denaturation solution until it 
absorbs enough solution, then the membrane was put on the blotting paper 
(colony side up) and incubated for 15 minutes. The neutralization solution was 
applied similarly for 5 minutes. Lastly, 2X SSC was applied  for 15 minutes to 
the membrane by the same method. Then the membrane was UV cross linked by 
UV Stratalinker 1800  at auto cross-link option. After that, the membrane was 
incubated in 3X SSC/0.1% SDS for 1 hour with shaking. After wiping the surface 
of the membrane by a wet towel, it was incubated for 1 hour at 37°C in TBS 
containing 20µg/ml proteinase K. To inactivate proteinase K, 40µg/ml PMSF in 
TBS was incubated with the membrane for 5 minutes at room temperature. Then 
the membrane was washed twice with 2X SSC for 5 minutes. After washing, the 
membrane was incubated with the blocking solution for 2 hours at 42 °C. Then 
the labeled probe was diluted to a concentration of 20 ng/ml in the blocking 
solution and hybridized for overnight at 68 °C. Next day, the membrane was 
washed twice with 2X wash solution for 5 minutes each. The washing step was 
repeated with 0.1 X wash solution for 15 minutes each.  Then the membrane was 
exposed to an X-ray film overnight at -80°C.  
 To confirm the positive signals, the positive colonies were picked up and 
grown  overnight at 37 °C. Then the colonies were suspended in normal saline 
and 2-3 drops were applied to membrane. Rest of the procedure was the same as 
explained above.  
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2.3.3.11 Immunofluorescence 
 Immunofluorescence was done to prove that 55 kDa protein bind to the 
complementary receptor on HPEC. HPEC were collected on a glass slide by the 
method described in section 2.3.3.7.1. 55 kDa protein (5µg) was incubated with 
the cells on the slide for 30 minutes. After washing the cells, the slide was 
blocked with 3% BSA to prevent the background signals. To remove the excess 
BSA the slide was washed with 0.01 M phosphate buffer, pH7,2. Then mAb 
against 55 kDa protein was incubated for 45 minutes on the slide at a 
concentration of 5 µg/ml (1:100 dilution). After washing three times with PB, 
secondary antibody conjugated to FITC was incubated for 45 minutes on the 
slide at a dilution of 1:500. After washing the excess antibody the slide was 
analyzed under fluorescence microscope. 
 
2.3.3.12 Isolation of Sol Phase of Sputum 
 The sol phase of sputum was collected by centrifuging at 15000 rpm for 90 
minutes at 4 °C. Supernatant was collected and kept at -80 °C until use. Among 8 
sputum samples obtained during RTI, 6 were pure M. catarrhalis infections and 
other two were M. catarrhalis mixed infection with H. influenzae and S. 
pneumoniae. 
 
2.3.3.13 Detection of Antibody in Patients’ Sputum 
 The 55 kDa protein (5 µg/lane) was subjected to SDS-PAGE. After 
transferring protein, PVDF membrane was treated with sol phase of the patients’ 
serum (1:100) for overnight at 4°C. HRP conjugated goat anti-human IgG, IgM 
and IgA at a dilution of 1:100 were used as a secondary antibody and treated for 
90 minutes at room temperature. 
 
2.3.3.14 Detection of Antibody in Rabbit Serum 
 The 55 kDa protein (1 µg/lane) was subjected to SDS-PAGE. After 
transferring the protein, PVDF membrane was treated with preimmune rabbit 
serum and immunized rabbit serum for strain B-88-152 and strain F at a dilution 
of 1:1000 for 90 minutes at room temperature. Peroxidase conjugated goat anti-
rabbit IgG at a dilution of 1:1000 was used as secondary antibody anf treated for 
90 minutes at room temperature. 
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CHAPTER 3: RESULTS 
 
3.1 INTRODUCTION 
 The results of our study can be divided into 3 parts. First, the protein of 
interest was isolated from the surface of M. catarrhalis, and the biochemical 
properties of the protein were determined (heat sensitivity, immunogenicity, 
glycosylation etc). Second, the function of the protein was confirmed by using 
attachment inhibition assays. In the third part we determined the N-terminal amino 
acid sequence of the protein and we attempted to amplify the partial gene of 55 kDa 
protein with PCR, sequence and clone the whole gene.  
 
3.2 ISOLATION AND CHARACTERIZATION OF 55 kDa PROTEIN  
 
3.2.1  Isolation of 55 kDa Protein  
 Figure 3.1 shows the elution profile of 55 kDa protein isolated by celite 
chromatography. As shown, protein peaks were found in elution fraction 9, 10, 11 
and 12. Figure 3.2 consists of SDS-PAGE profile of the corresponding proteins. We 
see a single band of protein with a molecular size of about 55 kDa at elution fraction 
9, 10, 11 and 12.  
 
Figure 3.1: Elution profile of celite chromatography. X-axis shows the elution 
fractions and the Y-axis shows the absorbance at OD280 
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Figure 3.2: Silver-stained gel after SDS-PAGE analysis of elution fractions 
showing pure protein was isolated with a molecular weight of 55 kDa. The numbers 
6~32 show the elution fractions subjected to electrophoresis. LM marker indicates 
the protein molecular weight marker and the numbers besides each band indicates 
their corresponding molecular weight in kDa.  
 
 
 
 
3.2.2 Biochemical Properties 
 The DIG Glycan Detection kit shows that 55 kDa protein is not glycosylated 
(Figure 3.3). To prove the validity of the test, we used glycosylated and 
nonglycosylated proteins, transferrin and creatinase as a positive and negative 
control, respectively. As seen in the Figure 3.3,  transferrin gave a positive signal 
while no signal was found for the 55 kDa protein and creatinase.  
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Figure 3.3: Glycosylation determined by DIG glycan detection kit. Glycosylation 
test was done after Western blotting of 55 kDa protein, transferrin (a glycosylated 
protein) and creatinase (a nonglycosylated protein). Only transferrin showed positive 
reaction, indicating creatinase and 55 kDa protein are nonglycosylated.  
 
   
 
Figure 3.4: Silver stained gel after SDS-PAGE of dithiothreitol(DTT), 2-
mercaptoethanol (ME) and heat treatment of 55 kDa protein. Control indicate 
unheated sample. No change of molecular weight of 55 kDa protein observed. 
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 To determine the heat sensitivity, 55 kDa protein was heated at 100 °C for 5 
minutes. In addition, to examine the presence of disulphide bonds, we treated the 
protein with dithiothreitol (DTT) and 2-mercaptoethanol separately. Moreover, in the 
presence of these reducing agents, samples were compared by heating at 100 °C for 5 
minutes with unheated samples. Silver staining of SDS-PAGE gel seen in Figure 3.4  
shows that our protein is resistant to heat, DTT and β-mercaptoethanol. 
 
3.2.3 Immunogenic Properties 
Western blot experiment shows that when rabbit was immunized with whole 
cell M. catarrhalis, it produced antibody against 55 kDa protein (Figure3.5). This is 
not only in the strain B-88-152 but also in strain F, which is a nonfimbriated strain. It 
indicates that 55 kDa is possibly conserved in other strains and not a fimbrial protein. 
We only used IgG as a secondary antibody as this is the dominant antibody in serum. 
 
 
Figure 3.5: Western blot of 55 kDa protein after membrane treated with antiserum 
of rabbit immunized with whole cell M. catarrhalis. No band is visible when 
membrane was treated with pre-immune rabbit serum(left). While positive band is 
visible after treatment with antiserum of rabbit immunized with M. catarrhalis strain 
B-88-152 (center) and strain F (right).  
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 To search whether the protein was immunogenic in humans, we did Western 
blot analysis to detect the antibodies against 55 kDa protein in patients’ sputum. 
After Western blot (figure 3.6), when the membrane was treated with sol phase of 
sputum, all the samples showed positive reactivity bands with IgG, IgM and IgA, 
indicating that the patients produced antibody against 55 kDa protein during the 
acute phase of M. catarrhalis infection in their sputum.   
 
Figure 3.6: Western blot analysis of the 55 kDa protein, detected three different 
types of antibodies (IgG, IgM and IgA) in sputa of patients infected with M. 
catarrhalis. Left side shows the protein molecular weight marker on PVDF 
membrane stained with Coomassie blue.  
 
3.2.4 N-Terminal Amino acid Sequence 
 The N-terminal amino acid sequencing determined 40 amino acids of 55 kDa 
protein which were found to be composed of the following amino acids: 
 KPSKIHTPSITHQNMLPSNTLAQLDALPQLTQGDGDTGKS……. 
 It may be noted that 55 kDa protein did not start with methionine.  Two other 
fragments of 55 kDa protein showed the following amino acid sequence  
 …..IHTPSITHQNMLPANTLAQ…… 
 …..KYDHXVKT……… 
X indicating the amino acid that could not be determined. 
  
3.1 EFFECT OF 55 kDa PROTEIN ON THE ATTACHMENT OF  M. 
CATARRHALIS 
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 To check whether 55 kDa protein is an adhesin of M. catarrhalis, we 
employed two strategies. In the first one, we incubated HPEC with exogenous 55 
kDa protein to find out whether the protein would block the receptor and inhibit the 
attachment. We also compared the attachment inhibition ability of an unrelated 
protein, BSA, using similar conditions. In the second strategy, we incubated the mAb 
against 55 kDa protein with M. catarrhalis to find out whether the antibody would 
bind to 55 kDa protein and would inhibit the attachment. We also compared the 
attachment inhibition ability of an unrelated commercially obtained mouse IgM. 
 
3.1.1 Attachment Inhibition Assay with 55 kDa Protein: 
 When cells were treated with 0.01, 0.1 and 1 µg /ml of 55 kDa protein, there 
was a significant decrease in attachment as shown in Table 3.1. On the other hand, at 
a concentration of 0.001and 0.0001 µg/ml, there was no difference of attachment as 
compared to the control. More significantly, we found a dose dependent effect 
between attachment inhibition and concentration of 55 kDa protein as shown in 
percentage data in Figure 3.7. Compared to the control (45.6 ± 6.6 bacteria /cell) 
there was no significant decrease of M. catarrhalis attachment, when cells were 
treated with 1 µg/ml of BSA (46.5 ± 15.6 bacteria/cell) 
 
 
 
 
Table3.1: Results of attachment inhibition assay with 55 kDa protein. Each 
experiment was done in duplicate and the values are expressed as mean ± SD. The 
values indicate number of bacteria attached per cell.  
Dilution  Control  Experiment 
No. of 
Exp 
0.0001µg/ ml  31.7±6.4  30.1±14.3 3 
0.001µg/ml  31.7±6.4  29.2±12.5 3 
0.01µg/ml  22.9±10.5  13.4±12.0 * 8 
0.1µg/ml  22.2±11.2  12.6±7.1 * 7 
1µg/ml  22.9±10.5  10.0±7.5 ** 8 
* p<0.05    
**p<0.005    
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Figure 3.7:Results of attachment inhibition assay with 55 kDa protein. Each 
experiment was done in duplicate and the values are mean of the experiments. The 
attachment of bacteria are shown here as percentage of the control. At a dose of 
0.0001, 0.001, 0.01,0.1 and 1 µg/ml, there was a 5%, 7.9%, 41.5%, 43.2% and 56.3% 
decrease of attachment when compared to the control, respectively. 
* p<0.05, **p<0.005  
 
 
 
 
 
3.1.2 Attachment Inhibition Assay with mAb Against 55 kDa Protein: 
 When bacteria were treated with 5 , 0.5 µg/ml of mAb, there was a significant 
decrease of attachment compared to the control (Table 3.2). However, no significant 
decrease of attachment was observed when bacteria were treated with 0.1µg/ml of 
mAb. In this experiment, also we found a dose dependent effect between attachment 
inhibition and concentration of mAb as shown in Figure 3.8. As compared to the 
control (19.4 ± 14.8 bacteria/cell) there was no significant decrease of M. catarrhalis 
attachment, when bacteria were treated with 5 µg/ml of unrelated mouse IgM (28.3 ± 
5.6 bacteria/cell).    
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Table3.2: Results of attachment inhibition by mAb against 55 kDa protein. Each 
experiment was done in duplicate and the values are expressed as mean ± SD. The 
values indicate number of bacteria attached per cell.  
Dilution  Control  Experiment 
No of 
Exp 
0.1 µg/ml  28.3±10.5  27.9±6.5  3 
0.5 µg/ml  30.6±4.1  14.8±11.5  * 5 
5 µg/ml  33.1±2.9  10.2±3.1  ** 3 
* p<0.05    
**p<0.01    
 
 
 
 
Figure 3.8: Results of attachment inhibition assay with mAb against 55kDa protein. Each experim
attachment compared to the control, respectively. 
* p<0.05 
**p<0.01 
 
 In addition, our mAb at a concentration of 5 µg/ml could inhibit the 
attachment of other 3 strains of M. catarrhalis significantly (Table 3.3).  
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Table3.3: Results of attachment inhibition of other strains by mAb. Each experiment 
was run in duplicate and the values are mean ± SD of at least three independent 
experiments. The values indicate number of bacteria attached per cell.  
Strain Control Experiment 
B-87-69 31.5±5.3 9.2±1.5  * 
B-87-94 11.8±4.0 3.0±2.3  * 
F 10.6±2.7 6.3±2.2  ** 
* p<0.05 
**p<0.01 
 
 
3.2 PCR Amplification of Partial Gene Encoding 55 kDa Protein 
 One way to sequence the gene encoding 55 kDa protein was to amplify it by 
PCR. Degenerate primers designed from the N-terminal amino acid sequence were 
employed. After optimizing the reaction conditions, we obtained a single band of 
500bp (Figure 3.9). After sequencing the PCR product we couldn’t find any 
homology with the N-terminal amino acid sequencing data.  
 
Figure 3.9: Agarose gel electrophoresis of PCR product. Lane 1: 1kb DNA ladder, 
lane 2&3: PCR product, lane 4: PCR reaction without template. The thick bands 
under the PCR product are excess primers.   
 
 
3.3 Immunofluorescence 
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To check whether 55 kDa protein really binds with HPEC, we performed 
immunofluorescence experiment. 60% of the cells treated with 55 kDa protein gave 
positive reaction while only 33.3% of the cells treated with PBS gave positive 
reaction. This result indicates that 55 kDa protein could bind to the receptor on 
HPEC and thus inhibits the attachment of M. catarhalis when cells were treated with 
55 kDa protein.  
 
3.6 MOLECULAR CLONING EXPERIMENTS 
 In this part of our study, we attempted to clone and sequence the gene 
encoding the 55 kDa protein. We used two strategies: first one was to make genomic 
DNA library of M. catarrhalis in pQE-31 expression vector and screen this library 
with the monoclonal antibody against 55 kDa protein. Before preparing such a 
library, a dot blot was performed to find out the reactivity of mAb with M. 
catarrhalis and E. coli. Figure 3.10 shows that the monoclonal antibody reacted only 
with M. catarhalis, but not with E. coli. 
 
 Figure3.10: Dot blot of M. catarrhalis and E. coli detected with monoclonal 
antibody against 55 kDa protein.  M. catarrhalis gave positive signal while no signal 
was found in E. coli colonies. 
 
3.6.1 Genomic Library in pQE-31 Expression Vector 
 The library was constructed by cutting the genomic DNA with HindIII and 
ligating the resulting fragments to linearized and dephosphorylated pQE-31 
expression vector.  The library was transformed into E. coli M15 strain and the 
expression was induced by IPTG. If 55 kDa protein was expressed on the surface of 
E. coli, it would be detected by the monoclonal antibody against 55 kDa protein. 
Finally, with colony lift we obtained 24 positive colonies after searching more than 
4000 colonies. Next, we made dot blot to confirm the results, this time we got 10 
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positive clones reacted with the mAb.  Then we sequenced these inserts and 
compared the results with the N-terminal amino acid sequence of 55 kDa protein. But 
we could not obtain any homology. However, the inserts were not sequenced up to 
the end, which remains to be done in future.  
 During the preparation of linearized plasmid DNA we encountered a problem 
that HindIII did not cut all the plasmid so that some uncut plasmid molecules 
remained. We solved the problem by excising the linear plasmid band from the gel 
and extracting the DNA from it. Figure 3.11 shows the linear and nonlinear forms of 
the pQE-31 vector.  
 
Figure 3.11: Agarose gel electrophoresis shows the pQE-31 plasmid vector after 
digested with HindIII and undigested form. DNA ladder molecular weight marker 
ranged from 10kb to 250 bp. The digested vector migrated at a size of 3.4 kb as 
expected. Arrow indicating the digested vector. 
 
 The inserts were prepared by digesting the genomic DNA of M. catarrhalis 
with HindIII. After running the digested DNA in agarose gel, the gel portion 
corresponding from 10 kb to 1 kb fragments was cut and purified by electroelution 
(Figure 3.12). 
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Figure 3.12: HindIII digested M. catarrhalis genomic DNA after electroelution. The 
fragments of the digested DNA were ranging between 1 kb and 10 kb. 
 
 After confirming the positive clones by dot blot, we isolated the plasmid 
DNA from recombinant E. coli and digested the plasmid with HindIII. After running 
the digest in agarose gel, different sizes of inserts were obtained e.g. 1 kb, 1.5 kb and 
3 kb.  An insert of ~3 kb can be seen in Figure 3.13.   
  
 
Figure 3.13: Agarose gel electrophoresis showing the plasmid (pQE-31) isolated 
from one of the putative clones. The insert was released upon digestion with HindIII 
is shown by the arrow. 
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3.6.2 Genomic Library in pBluescript SK Vector 
 As our second strategy, the library was prepared with pBluescript SK 
(pBSK) vector. Similarly, the genomic DNA of M. catarrhalis was cut with five 
different restriction enzymes (EcoRV, PstI, HindIII, DraII and BstXI). Among these, 
EcoRV, PstI and HindIII cut well while the restriction digestions obtained from 
DraII and BstXI were not satisfactory. Thus, EcoRV, PstI and HindIII  were used to 
construct the library. The fragments of the digested DNA were ligated into linearized 
and dephosphorylated pBluescript vector. Figure 3.13 and 3.14 show the inserts and 
the vector. 
 
Figure 3.14: M. catarrhalis genomic DNA was digested by different restriction 
enzymes. pBluescript (pBSK) plasmid DNA was included for comparison of DNA 
concentrations.  
 
Figure 3.15: M. catarrhalis genomic DNA and pBluescript (pBSK) plasmid DNA 
were digested with EcoRV. Uncut plasmid is also shown. 
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 The library was then transformed into E. coli DH5α strain. After screening 
the library as explained in Chapter 2, we obtained a total of 10 positive colonies 2 of 
which are shown in Figure 3.15. We made dot blot of all these 10 positive clones to 
confirm the results and 2 of these positive clones gave positive reaction again. Inserts 
from these clones were sequenced but there was no homology between the N-
terminal amino acid sequence of 55 kDa protein and the 3-frame translations of the 
inserts. 
 
Figure 3.16: Screening of HindIII-pBluescript genomic library of M. catarrhalis 
with radiolabelled probe. The arrows indicated the positive colonies.  
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CHAPTER 4: DISCUSSION 
 
 Bacterial adhesion to host cells is the initial step of the colonization and 
subsequent infection. Although human body develop defense against bacterial 
attachment, there are some bacteria that can still attach to human host and can 
cause disease. Our body has developed several means to prevent attachment. For 
instance, presence of normal flora in the upper respiratory tract prevents 
attachment of several pathogenic bacteria by occupying space in the respiratory 
tract. In addition, IgA in our mucus prevent attachment of bacteria to the 
epithelial cells (Williams 1972). On the other hand, some bacteria secrete IgA 
protease, which degrades specifically IgA, and thus overcome this defense 
(Zakrzewski 2000). It is not certain whether M. catarrhalis also uses this protease 
as a virulence factor.  
 The bacterial surface constitutes the first line of defense against antimicrobial 
molecules and stress caused by the environment surrounding the bacterium. In 
the case of host-pathogen interactions, many bacterial surface molecules are 
virulent determinants. Thus, in order to understand the molecular basis for 
bacterium-host interactions, it is important to characterize the molecular 
architecture of the bacterial cell surface. In the present study we have isolated 
and characterized a surface protein from M. catarrhalis, which mediates 
attachment to human pharyngeal epithelial cells. 
 The isolation of surface proteins was done by “water extraction method”, 
which has been applied to Campylobacter jejuni (Pie 1988) and H. influenzae (Lu 
1998) to extract surface proteins. Our initial findings showed that we could 
extract different types of proteins from M. catarrhalis by this method. This water 
extract was applied to celite chromatography in order to isolate a putative adhesin 
protein. Celite chromatography has been successfully used in the isolation of 
adhesin from H. influenzae (Lu 1998). In this technique, the hydrophobic 
interaction is thought to be involved between the proteins and the celite (Queiroz 
2001). 
 Our attachment inhibition assay conclusively showed that 55 kDa protein is 
an adhesin of M. catarrhalis. When we treated HPEC with 55 kDa protein, the 
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attachment inhibition was achieved at a very low concentration of protein and 
there was a dose dependent effect also, yet, there was no effect when we treated 
cells with BSA. Similarly when we treated M. catarrhalis with mAb against 55 
kDa protein, we achieved attachment inhibition at a low concentration of 
antibody. There was a dose dependent effect also in this antibody mediated 
attachment inhibition assay. On the other hand, unrelated mouse IgM had no 
effect on attachment inhibition. As a support to these data, our 
immunoflourescence results conclusively proved that 55 kDa protein indeed can 
bind with HPEC. We also showed that the mAb was effective in attachment 
inhibition of other strains of M. catarrhalis, which indicates that 55 kDa protein 
might have been conserved among different strains of M. catarrhalis. Therefore 
this protein may be designated as a virulence factor for M. catarhalis which is 
essential for attachment with host cells and for subsequent infection. 
 There are several research groups studying adherence mechanism of M. 
catarrhalis. However, cultured cells are used in those experiments (McMichael 
1998). But cultured cells are transformed cells which might have several 
mutations in the genome that make them to express aberrant receptors 
(Barthelson 1998). However, we used normal epithelial cells taken freshly from a 
healthy adult. Therefore our method might more truly reflect the mechanism 
which occurs in vivo.    
 The concept of conserved nature of the protein and its immunogenicity get 
support from our experiments where we showed that antibodies against the 55 
kDa protein is generated when we injected the whole cell M. catarrhalis into 
rabbit and also in sputum from patients infected with M. catarrhalis. The rabbit 
antiserum experiment also indicates that 55 kDa protein is indeed a surface 
protein, otherwise antibodies against this protein would not be generated by 
immunizing with whole cell M. catarrhalis. Fimbriae have been found as an 
adhesin in different types of bacteria as well as in M. catarhalis. The antiserum 
generated with a nonfimbriate strain also showed reactivity with 55 kDa protein. 
This indicates that our protein is not a fimbrial protein. Therefore it appears that a 
new adhesin has been found in this study.  
 As M. catarrhalis is a mucosal pathogen, we were interested to see whether 
the antibody molecules against 55 kDa produced in sputum during M. catarrhalis 
infection. Although many other studies showed that antibodies against some 
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putative virulence factors are found in the serum of patients with M. catarrhalis 
infection, it is more important to detect antibody in the sputum since this is a 
mucosal pathogen. We showed that IgG, IgA and IgM  are all produced against 
55 kDa protein in sputa of these patients. Therefore whatever approach is taken 
for immunization, that is systemic or local, antibodies against 55 kDa protein can 
be induced in human. Various types of antibody have various types of function; 
therefore different isotypes of antibodies generated in patients against 55 kDa 
protein might have a role in M. catarrhalis infection. Taken this immunogenic 
potential in both animal and human, 55 kDa protein may be designated as a 
potential vaccine candidate for M. catarhalis. 
 Several very important points came out from the biochemical characterization 
of the protein in this study. This is a heat stable protein means its preservation is 
relatively easy which is an important criterion for a vaccine candidate. The 
protein was also unchanged after treatment with reducing agents indicates that 
any disulphide bond between cysteine residues is absent in this protein. This 
information might be helpful in future, to elucidate the structure function 
relationship of 55kDa protein. 
 Certainly the best result we obtained was the BLAST search performed using 
the N-terminal amino acid sequence of 55 kDa protein. The search found no 
significant homology with the available sequence of proteins, indicating 55 kDa 
protein is a novel one. Future study may be directed to find out if it is present 
only in M. catarrhalis. This will make a significant contribution to the clinical 
microbiology laboratories in the identification of M. catarrhalis for the benefit of 
patients. 
We could not find homology between the sequence of PCR product and the 
sequence of N-terminal amino acids. The reason is most probably the inability of 
the sequencer to read the initial 60 bases of the PCR product. Therefore, possibly,  
N-terminal amino acid sequence corresponded to the region that could not be 
read. The solution to this problem  is to clone the PCR product into a TA cloning 
vector, which enables the cloning of PCR products. Then by using the 
sequencing primers designed for this vector, we would be able to sequence the 
gene. 
 Sequencing all the inserts of pQE-31 vector did not match with the N-
terminal amino acid sequence either. An interesting finding was that the 
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sequences of different inserts were not similar except for two of them. This raised 
the possibility that there were different fragments sharing the same epitope. Or 
the same gene was cut by HindIII in a way that there occurred more than one 
inserts containing the same epitope i.e. 1kb, 1.5 kb and 3 kb inserts containing 
the same gene segment. Another explanation is that we got false-positive results. 
However, this is of low probability because we confirmed the results by dot blot.  
 We did not search for open reading frame in the sequences of inserts 
because the sequencer could insert or remove one base or change one base. So if 
there were such an error it would change the frame completely. Instead we 
translated the sequence in all reading frames and compared them all with the N-
terminal amino acid sequence even if there was a stop-codon. In future inserts of 
all the positive clones can be sequenced up to the end.  
Sequencing of positive clones of colony hybridization did not give any 
homology with the N-terminal amino acid sequence and there was no homology 
with the oligonucleotide probe that was used to screen the library. However, we 
sequenced only 400 bp of the inserts, which were 750 bp, and 1200 bp in length. 
In future, the remaining part of the inserts should be sequenced, which might lead 
us to identify the whole gene of interest.   
 
4.1 Conclusion 
In this project a surface protein of M. catarrhalis has been isolated and 
characterized. It is demonstrated by two kinds of attachment inhibition assays  
that this protein is involved in the attachment process of M. catarrhalis.  We also 
found from animal and human study that 55 kDa protein is immunogenic. 
Therefore, two conclusions can be drawn from this project: First, the protein is an 
adhesin and it has a therapeutic potential regarding the attachment process. 
Second, it is a surface protein and it is a potential vaccine candidate.  
We used water extraction combined with celite chromatography to isolate the 
55 kDa protein. This method is simple and efficient since plenty of protein can be 
isolated without any contamination. Therefore the method is suitable for mass 
production for future use.  
We successfully constructed genomic libraries therefore in future the libraries 
can be used in future to identify the gene encoding 55 kDa protein or other gene 
of M. catarhalis.  
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4.2 Future Perspectives 
 In the continuation of this project, all the positive clones identified by 
antibody screening could be sequenced up to the end and checked whether they 
match with the N-terminal sequence. In future, it may also be possible to express 
55 kDa gene on the surface of E. coli and determine the attachment ability 
compared to the wild type E. coli strain. Since E. coli is not a respiratory 
pathogen, the difference of attachment ability will further prove as to whether 55 
kDa protein as an adhesin of M. catarrhalis.  
 In this study, we prepared genomic DNA libraries in pQE-31 and pBluescript 
SK vector. We confirmed that the library  was constructed successfully by 
sequencing the positive inserts for pQE-31 library i.e. each colony in the library 
contains a different insert. In the case of pBSK libraries, we checked the quality 
of the libraries by X-gal (blue-white) selection. The  libraries were highly 
efficient to be used in future to clone any gene of M. catarrhalis. 
  The immunogenic properties of a protein are important when considering it as 
a vaccine candidate. In this study, we have shown that 55 kDa protein is 
immunogenic in rabbit and in human. However, four other approaches should be 
taken in future to find out the significance of antibodies against 55 kDa in 
human: 
1. Whether these antibodies against 55kDa protein decrease during 
convalescent or later period of infection 
2. What other function these antibodies might have? (For example 
opsonophagocytic potential or complement induction, etc.) 
3. Whether these antibodies protective in animal models of infection. 
However as stated before there is no good animal model for M. 
catarrhalis infection. 
4. Whether the 55 kDa protein is conserved among different strains of 
M. catarhalis? 
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